RegeneRX Investors - News Releases https://www.regenerx.com/ RegeneRx Effects Reverse Stock Split and Terminates SEC Reporting Obligations https://www.regenerx.com/2023-08-15-RegeneRx-Effects-Reverse-Stock-Split-and-Terminates-SEC-Reporting-Obligations Tue, 15 Aug 2023 08:00:00 -0400 https://www.regenerx.com/2023-08-15-RegeneRx-Effects-Reverse-Stock-Split-and-Terminates-SEC-Reporting-Obligations RegeneRx Receives Stockholder Approval for Reverse Stock Split https://www.regenerx.com/2023-08-07-RegeneRx-Receives-Stockholder-Approval-for-Reverse-Stock-Split Mon, 07 Aug 2023 16:06:00 -0400 https://www.regenerx.com/2023-08-07-RegeneRx-Receives-Stockholder-Approval-for-Reverse-Stock-Split RegeneRx To Extend Consent Solicitation Vote https://www.regenerx.com/2023-08-01-RegeneRx-To-Extend-Consent-Solicitation-Vote Tue, 01 Aug 2023 12:34:00 -0400 https://www.regenerx.com/2023-08-01-RegeneRx-To-Extend-Consent-Solicitation-Vote First Patient Enrolled into U.S. Phase 3 Neurotrophic Keratitis Clinical Trial with RGN-259 https://www.regenerx.com/2023-04-13-First-Patient-Enrolled-into-U-S-Phase-3-Neurotrophic-Keratitis-Clinical-Trial-with-RGN-259 Thu, 13 Apr 2023 08:04:00 -0400 https://www.regenerx.com/2023-04-13-First-Patient-Enrolled-into-U-S-Phase-3-Neurotrophic-Keratitis-Clinical-Trial-with-RGN-259 RegeneRx Issues Letter To Stockholders https://www.regenerx.com/2023-04-11-RegeneRx-Issues-Letter-To-Stockholders Tue, 11 Apr 2023 16:59:00 -0400 https://www.regenerx.com/2023-04-11-RegeneRx-Issues-Letter-To-Stockholders